author-photo

Olayemi Osiyemi

26

Papers

414

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.

2021 AIDS
Show All
- Source
- Cite
- Save
Citations (0)
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

2021 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (2)
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide In Black Americans with HIV-1: a Randomized Phase 3b, Multicenter, Open-Label Study

2021 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (0)
1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose Two-Drug Regimen Versus Continuing a Tenofovir Alafenamide-Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1: Phase 3, Randomized, Non-inferiority TANGO Study.

2020 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (65)
116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial

2019 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (12)
Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen

2019 Hiv Medicine
Show All
- Source
- Cite
- Save
Citations (12)
Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies

2018 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (8)
Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

2018 Infectious Diseases and Therapy
Show All
- Source
- Cite
- Save
Citations (9)